Combinations of akt inhibitor compounds and erlotinib, and methods of use

• 收藏
• 分享

专利权人:

GENENTECH INC.

发明人:

NANNINI MICHELLE,SAMPATH DEEPAK

申请号：

NZ61724612

公开号：

NZ617246A

申请日:

2012.03.30

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

Disclosed is a combination of, a) the compound of Formula (I) 2-(4-chlorophenyl)-3-(isopropylamino)-1-(4-((R)-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)propan-1-one (GDC-0068/ipatasertib) or a pharmaceutically acceptable salt thereof； and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/